4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-24-006984
Chief Executive Officer acquired 175,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| De Backer Marianne Chief Executive Officer | 2024-02-22 | Grant or award | +175,000 | 751,452 | D | ||
| Derivatives | |||||||
| De Backer Marianne Chief Executive Officer | 2024-02-22 | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | D | ||
Loading xslF345X05/wk-form4_1708993962.xml…